[Phentonium plus perphenazine?].
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy; D000704:Analysis of Variance; D001007:Anxiety; D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D003201:Computers; D004341:Drug Evaluation; D004357:Drug Synergism; D004361:Drug Tolerance; D004415:Dyspepsia / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000188:drug therapy; D010546:Perphenazine / Q000008:administration & dosage / Q000627:therapeutic use*; D010648:Phenylacetates / Q000008:administration & dosage / Q000627:therapeutic use; D012893:Sleep Wake Disorders / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014839:Vomiting / Q000188:drug therapy
D001713:Biphenyl Compounds; D010648:Phenylacetates; D014149:Tranquilizing Agents; D001285:Atropine; D010546:Perphenazine
Fentonio plus perfenazina?